Prolonged efficacy of a single dose of the bisphosphonate zoledronic acidBROWN, Janet E; ELLIS, Susan P; LESTER, James E et al.Clinical cancer research. 2007, Vol 13, Num 18, pp 5406-5410, issn 1078-0432, 5 p., 1Article

Ostéonécroses de mâchoire liées aux diphosphonates = Osteonecrosis of the jaws related with the use of bisphosphonatesLa Revue Prescrire. 2007, Vol 27, Num 288, pp 747-749, issn 0247-7750, 3 p.Article

p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acidKURODA, Junya; KIMURA, Shinya; MAEKAWA, Taira et al.Cancer science. 2004, Vol 95, Num 2, pp 186-192, issn 1347-9032, 7 p.Article

Routes to calcified porous silicon: implications for drug delivery and biosensingCOFFER, Jeffery L; MONTCHAMP, Jean-Luc; AIMONE, James B et al.Physica status solidi. A. Applied research. 2003, Vol 197, Num 2, pp 336-339, issn 0031-8965, 4 p.Conference Paper

Zoledronate : Efficacy and safetyREID, Ian R.Journal of bone and mineral research (Print). 2006, Vol 21, issn 0884-0431, P83-P87, SUP2Conference Paper

Successful treatment of multicentric reticulohistiocytosis with alendronate: Evidence for a direct effect of bisphosphonate on histiocytesGOTO, Hitoshi; INABA, Masaaki; KOBAYASHI, Keisuke et al.Arthritis and rheumatism. 2003, Vol 48, Num 12, pp 3538-3541, issn 0004-3591, 4 p.Article

Effect of topical alendronate treatment on fixation of implants inserted with bone compactionJAKOBSEN, Thomas; KOLD, Søren; BECHTOLD, Joan E et al.Clinical orthopaedics and related research. 2006, Num 444, pp 229-234, issn 0009-921X, 6 p.Article

Risedronate on Two Consecutive Days per MonthFRAMPTON, James E.Drugs & aging. 2009, Vol 26, Num 4, pp 355-362, issn 1170-229X, 8 p.Article

Alendronate in bone cement : Fatigue life degraded by liquid, not by powderLEWIS, Gladius; JANNA, Si.Clinical orthopaedics and related research. 2006, Num 445, pp 233-238, issn 0009-921X, 6 p.Article

Ibandronate : Pharmacology and preclinical studiesRUSSELL, R. G. G.Bone (New York, NY). 2006, Vol 38, Num 4, issn 8756-3282, S7-S12, SUP1Article

Successful treatment of osteolytic epithelioid hemangioendothelioma with pamidronateCOPPO, P; LASSOUED, S; BILLEY, T et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 3, pp 400-401, issn 0392-856X, 2 p.Article

Sclerotic metaphyseal lines in a child treated with pamidronate: Histomorphometric analysisRAUCH, Frank; TRAVERS, Rose; MUNNS, Craig et al.Journal of bone and mineral research (Print). 2004, Vol 19, Num 7, pp 1191-1193, issn 0884-0431, 3 p.Article

The emerging role of bisphosphonates in the prevention of bone metastasesPATERSON, A. H. G.Trends in endocrinology and metabolism. 1999, Vol 10, Num 1, pp 24-29, issn 1043-2760Article

Newer bisphosphonates in the treatment of Paget's disease of bone : Where we are and where we want to goGRAUER, A; BONE, H; MCCLOSKEY, E. V et al.Journal of bone and mineral research (Print). 1999, Vol 14, pp 74-78, issn 0884-0431, SUP2Conference Paper

Effects of ibandronate on bone quality : Preclinical studiesBAUSS, F; DEMPSTER, D. W.Bone (New York, NY). 2007, Vol 40, Num 2, pp 265-273, issn 8756-3282, 9 p.Article

Ulcérations buccales dues aux diphosphonates = Severe oral mucosa ulcerations induced by biphosphonatesLa Revue Prescrire. 2007, Vol 27, Num 283, pp 358-358, issn 0247-7750, 1 p.Article

Alleviation of polyarticular syndrome in multicentric reticulohistiocytosis with intravenous zoledronateMAVRAGANI, C. P; BATZIOU, K; ARONI, K et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 10, pp 1521-1522, issn 0003-4967, 2 p.Article

Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis : a pilot studyRINGE, J. D; DORST, A; FABER, H et al.Rheumatology international (Berlin. Print). 2005, Vol 25, Num 4, pp 296-300, issn 0172-8172, 5 p.Article

Severely suppressed bone turnover : A potential complication of alendronate therapyODVINA, Clarita V; ZERWEKH, Joseph E; SUDHAKER RAO, D et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 3, pp 1294-1301, issn 0021-972X, 8 p.Article

Bioequivalence studies on bisphosphonates: The example of alendronateLAINESSE, Audrey; OZALP, Yildiz; HONG WONG et al.Arzneimittel-Forschung. 2004, Vol 54, Num 9A, pp 569-572, issn 0004-4172, 4 p.Article

Bisphosphonates for the treatment of Charcot neuroarthropathyANDERSON, John J; WOELFFER, Kirk E; HOLTZMAN, John J et al.The Journal of foot and ankle surgery. 2004, Vol 43, Num 5, pp 285-289, issn 1067-2516, 5 p.Article

What can nano-chemistry offer to the paint industry ?FELHÖSI, I; TELEGDI, J; PAPP, K et al.Die Makromolekulare Chemie. Macromolecular symposia. 2002, pp 305-315, issn 0258-0322, isbn 3-527-30477-7Conference Paper

Effect of precipitating conditions on the formation of calcium-HEDP precipitatesBROWNING, F. H; FOGLER, H. S.Langmuir. 1996, Vol 12, Num 21, pp 5231-5238, issn 0743-7463Article

Diez casos de osteonecrosis mandíbular (ONM) asociada a bisfosfonatos = Ten cases of osteonecrosis of the jaw related with biphosphonatesFERREIRO, S. Varela; OZORES, P. Palacios; SALGADO BOQUETE, L et al.Oncología (Barcelona). 2007, Vol 30, Num 4, pp 13-21, issn 0378-4835, 9 p.Article

Ibandronate : Un nouveau bisphosphonate par voie orale = Ibandronate : a new oral bisphosphonateThe Medical letter on drugs and therapeutics (Edition française). 2005, Vol 27, Num 11, pp 55-56, issn 0253-8512, 2 p.Article